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Abatraet-The effects of nisoldipine (0.1 ,ug/kg/min; n = 9) or its solvent (n = 9) were studied in pigs, 
in which left anterior descending coronary artery (LADCA) blood flow in both groups was reduced to 
20% of baseline for 60 min and reperfused for 2 hr. Infusions were started at 30 min of ischaemia and 
lasted throughout reperfusion. In both groups, flow reduction abolished regional contractile function 
and caused similar decreases in the level of creatine phosphate (CP; by 70%) and the energy charge 
(from 0.91 to O-69), mean arterial blood pressure (by 25%), LVdP/dt,,, (by 30%) and cardiac output 
(by 30%). During ischaemia LADCA blood flow slightly increased (from 14 rt 8 to 24 & 6 mL/min/ 
100 g; P < 0.05) in the nisoldipine-treated animals, resulting in an increase in CP to 91 2 24% of baseline 
and preventing further decreases in energy charge, as observed in the solvent-treated animals. After 
2 hr of reperfusion in neither group return of contractile function of the post-ischaemic myocardium was 
observed. Post-ischaemic blood flow in the nisoldipine-treated pigs increased from 24 * 6 mL/min/~~ g 
to 76 f 14 mL/min/lOO g and from 19 2 6 mL/min/lOO g to 41 -C 6 mL/min/lOQ g in the solvent-treated 
animals (P < 0.05) after 2 hr of reperfusion. Myocardial work was significantly higher in the nisoldipine- 
treated animals (111 * 1.5 mmHg.L/min as compared to 69 -C 14 mmHg.L/min in the solvent-treated 
pigs after 2 hr of ischaemia). The energy charge of the post-ischaemic myocardium was similar for both 
groups (0.84 2 0.02 for the nisoldipine-treated and 0.83 -C 0.03 for the solvent-treated animals). The 
rate of sarcoplasmic reticular Caz+ uptake of the non-ischaemic segment of the nisoldipine-treated 
animals was 61% higher (P < 0.05) than that of the solvent-treated animals. In the post-ischaemic 
my~ardium similar rates of Ca” uptake were found in both groups, but the activities were markedly 
lower as compared to the non-ischaemic myocardium. It is concluded that ni~ldipine increases blood 
flow during reperfusion, which may have been caused by coronary vasodilatation. However, attenuation 
of the”no-reflow” phenomenon also contributed, since more rapid rephosphorylation f ADP leading 
to an increase in CP during ischaemia may have preserved jeopardized cells. Moreover, nisoldipine 
increases the sarcoplasmic reticular CaZ+ pump activity independent of ischaemia, which may have 
contributed in reducing the Ca*+ overload. 
The rapid and uncontrolled increase in cytosolic 
Ca2+ that occurs upon reperfusion of ischaemic 
my~ardia~ tissue is believed to play a central role 
in the subsequent loss in cell viability. The Ca2+ 
overload triggers a chain of destructive events. 
Activation of Ca2+-dependent reactions such as 
ATPases, proteases and phospholipases result in 
energy waste and membrane disruption. The 
cytosolic free Ca2+ concentration can increase by 
entrance via the Na+:Ca*+ antiporter [I], via 
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receptor- and voltage-operated Ca2’ channels and, 
as the cell membrane ~sintegrates via passive 
di~usion 121. The loss in ability of the sarco~emma 
and sarcoplasmic reticulum (SRO) to remove Ca2+ 
from the cytosol could also contribute to cytosolic 
Ca2+ overload. Ischaemia causes a reduction in 
active Ca*+ transport rate of sarcoplasmic reticulum 
[3] and sarcolemma [43. Ca2+ entry blockers are 
specific blockers of the voltage-operated Ca2+ 
channels [5] and therefore have the potential to 
protect the myocardium against Ca” overload 161. 
Moreover, some dihydrop~idines (nitrendipine and 
feiodipine) have been shown to directly stimulate 
the in vitro Ca2+ uptake rate of canine sarcoplasmic 
reticulum, which may present another potential 
action site to prevent myocardial Ca2+ overload [7]. 
The activity of the sarcoplasmic reticulum 
Ca2+ pump is modulated by phospholamban 
phosphorylation [8,9]. Experiments conducted with 
intact hearts indicate that cyclic AMP- and Ca2*- 
induced phosphorylation of phospholamban is 
involved in the j3-adrenergic activation of the calcium 
pump of the SR [lo]. We obtained evidence that the 
ischaemia-induced inactivation of the calcium pump 
43 
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is a consequence of the altered characteristics of 
phospholamban and may be of value as an early 
marker of long-term recovery of function following 
reperfusion of ischaemic myocardium [3]. 
In addition to their vasodilatory potential, leading 
to increases in blood flow to the area at risk and 
sparing of energy, Ca?+ entry blockers can also 
preserve myocardium by avoiding the loss of 
adenosine precursors 1111, protect the vascuiar 
endotheliai cells independent of vasodilatation [ 121, 
beneficially interact with the sarcolemma membrane 
[13] and mitochondria [14] of the myocardial cell. 
By protecting the myocardium via these mechanisms, 
Ca2+ antagonists may also indirectly prevent the 
reduction in the Ca*+ uptake and phospholamban 
phosphoryiation of sarcoplasmic reticulum of post- 
ischaemic myocardium. 
The present study was conducted to investigate 
the effects of nisoldipine, given 30 min prior to and 
throughout reperfusion, on the Ca*+ transport 
activity and in vitro 32P incorporation into phospho- 
lamban of SR, isolated from large transmural 
myocardial segments of pigs subjected to 1 hr of 
ischaemia followed by 2 hr of reperfusion. In view 
of the relative lack of data on the effects of 
nisoldipine on energy metabolism in an in z&lo 
model, other biochemical parameters such as the 
energy charge and levels of creatine phosphate (CP) 
were measured in small transmural myocardial 
biopsies collected during ischaemia and reperfusion. 
Additionally, the effects of the drug on systemic 
haemodynamics, regional contractile function and 
coronary blood flow were investigated. 
MATERIALS AND METHODS 
General. After an overnight fast cross-bred 
Landrace X Yorkshire pigs of either sex (N = 18, 
25-42 kg) were sedated with 120 mg azaperone 
(Janssen Pharmaceutics, Beerse, Belgium) i.m., 
anaesthetized with 150 mg metomidate (Janssen 
Pharmaceutics), i.v. and intubated for artificial 
ventilation with a mixture of oxygen and nitrous 
oxide (1: 2). Respiratory rate and tidal volume were 
adjusted to keep arterial blood gases within the 
normal range: pH between 7.37 and 7.49; pCOz 
between 34 and 48mmHg; pOZ between 120 and 
180mmHg. A catheter was positioned into the 
superior caval vein for the administration of 160 mg/ 
kg cY-chloralose (Merck, Darmstadt, F.R.G.) 
followed by an infusion of5 mg/kg/hr pentobarbitone 
sodium (Sanofi, Paris. France) and for the 
administration of the muscle relaxant pancuronium 
bromide (4mg) prior to thoracotomy. Haemaccel 
(Behringwerke A.G., Marburg, F.R.G.) was admin- 
istered to replace the blood, withdrawn during 
sampling (see below). An SF micromanometer- 
tipped catheter (Millar, Houston, TX, U.S.A.) was 
inserted into the left ventricle by way of the left 
carotid artery, for the measurement of left ventricular 
blood pressure and its first derivative (LVdP/dt). 
Catheters were also inserted into the aorta. for 
measurement of central aortic blood pressure (50 
AD pressure transducer, Spectramed, Bilthoven, 
The Netherlands), the collection of blood samples 
for the determination of blood gases and for the 
withdrawal of reference samples necessary for 
calibration of the radioactive microsphere flow 
measurements. After thoracotomy, an elec- 
tromagnetic flow probe (Skalar, Delft, The Nether- 
lands) was placed around the ascending aorta for 
the measurement of aortic blood flow. The left 
anterior descending coronary artery (LADCA) was 
dissected free just distal from its first diagonal branch 
and an inflatable balloon (R. E. Jones, Silver Spring, 
MD, LJ.S.A.) was placed around the LADCA and 
connected to a 1 mL syringe (Hamilton Bonaduz, 
Bonaduz, Switzerland) driven by a micrometer 
(Hamilton Co., Rena, NV, U.S.A.). The vein 
accompanying the LADCA was cannulated for the 
withdrawal of blood samples for the determination 
of coronary venous blood gases. 
Regional 6iood~o~,. To determine regional blood 
flows the left atria1 appendage was catheterized for 
the injection of a batch of l-2 x 10h radioactive 
microspheres, 15 t 1 (SD) pm in diameter (NEN 
Company, Dreieich, F.R.G.), labelled with either 
y5Nb, lo3Ru. ““Sn. 4hS~ or 14’Ce. Full details of the 
procedures and the calculation of flow data using 
the reference sample technique have been reported 
earlier [lS, 16]. 
Regional m~ocardial junction. Regional myo- 
cardial function was estimated from recordings of 
myocardial wall thickness obtained with a 5 MHz 
ultrasonic transducer (Krautkamer-Branson, Lewis- 
town. PA, U.S.A.) sutured onto a part of the 
epicardial surface perfused by the LADCA. From 
the tracings end-diastolic (EDT), end-systolic (EST) 
and maximal post-systolic (maxT) wall thickness 
were measured. Systolic wall thickening (.SWT,%) 
was calculated as 100 x (EST - E~~~E~T, while 
post-systolic wall thickening (PSWT, % j was defined 
as 100 x (maxT - EST)/EDT. 
Experimental protocol. After systemic haemo- 
dynamics had been stable for at least 30 min following 
completion of the instrumentation, baseline values 
of systemic haemodynamics. regional myocardial 
function and arterial and coronary venous blood 
gases were obtained while a batch of microspheres 
was injected for the measurement of distribution of 
myocardial blood flow. Furthermore, transmural 
needle biopsies (processed as described below) were 
taken from the myocardium nourished by the distal 
part of the LADCA and from a segment of the 
anterior wall of the heart, which was not supplied 
by the LADCA. In all pigs the flow in the LADCA 
was then gradually reduced by slowly inflating the 
balloon. until complete loss of regional contractile 
function, After 30min of ischaemia, the measure- 
ments of systemic haemodynamics and regional 
blood Rows were repeated and a transmural biopsy 
was taken from the ischaemic area. In nine animals 
an infusion of nisoldipine (0.1 pg/kg/min) was 
started and in the other animals solvent was 
administered at a similar infusion rate (1 mL/min). 
If ventricular fibrillation occurred the animal was 
promptly (within 30sec) defibrillated with DC- 
countershock. After 60 min, when all measurements 
had been repeated and biopsies were obtained from 
both the ischaemic and the non-ischaemic area, the 
balloon was deflated. Two hours later, the last 
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haemodynamic measurements were taken and 
biopsies were collected. The heart was then excised 
and immediately cooled on ice and transmural 
myocardial samples (5-7 g) were obtained from the 
post-ischaemic segment and from the posterior wall 
of the heart (non-ischaemic segment). The segments 
were homogenized for isolation of SR membrane 
vesicles (see below). Furthermore, the radioactive 
label present in the pellet after the first centrifugation 
step (10,000 g, 20 min) for SR isolation was counted 
in order to obtain myocardial blood how data. 
Adenine nucleotides, creatine phosphate and 
creatine. The transmural myocardial biopsies, taken 
with a Tru-Cut needle (Travenol Laboratories Inc., 
Deerfield, IL, U.S.A.) from the ischaemic area and 
the adjacent non-ischaemic area were dipped into 
0.9% NaCl of 0” to remove adherent blood, and 
immediately (within 10 set) frozen in liquid nitrogen. 
The biopsies were stored at -80” until analysis. The 
biopsies (5-20 mg) were homogenized in 0.5 mL 
0.42 M HC104 at liquid nitrogen temperature 
with the Braun micro-dismembrator (B. Braun, 
Melsungen, F.R.G.), thawed, shaken and centri- 
fuged. After neutralization of the supernatant the 
adenine nucleotides, CP and creatine were separated 
and the concentrations estimated with an isocratic 
ionpairing high performance liquid chromatography 
(HPLC) [1711 except that 175 mM potassium 
phosphate, 2.3 mM tetrabutylammonium hydro- 
gensulfate, 2.5% acetonitrile, pH 6.25 was used as 
a running buffer. With this HPLC method we also 
checked the purity of the [y-r*P]ATP used in the 
phospholamban phosphorylation assays. 
Isolation of sarcoplasmic reticulum. The transmural 
myocardial tissue samples were homogenized three 
times during 10 set in 4 volumes of 10 mM NaHC03, 
pH7.0 at 0” with a Polytron PT 10 (Kinematica 
GmbH, Luzern, Switzerland). The SR was isolated 
as described [3]. Immediately after isolation, the SR 
suspension was frozen in liquid nitrogen and stored 
at -80” until analysis of Ca*+ uptake and 
phospholamban phosphorylation activities. 
Phosphorylation of phospholamban and Ca*+ 
uptake activity. The cyclic AMP-dependent phos- 
phorylation of SR vesicles (5-1Opg protein) was 
determined as described [3] with 5 PM cyclic AMP 
to activate the endogenous protein kinase and 300 
units/ml exogenous catalytic subunit of cyclic AMP- 
dependent protein kinase (Sigma Chemical Co, St 
Louis,MO, U.S.A.). Thesamples werepreincubated 
for 2 min at 25” and the phosphorylation reaction 
was started by the addition of 200pM (final 
concentration) [Y-~*P]ATP (150 TBq/mol). After 
5 min the reaction was stopped with a mixture of 
sodium dodecylsulphate (SDS), /3-mercaptethanol 
and glycerol [3,18]. The samples were then heated 
at 95” to dissociate phospholamban into monomers, 
and subjected to SDS-polyacrylamide gel electro- 
phoresis [18]. Phosphorylated phospholamban was 
located on dried gels by autoradiography and 32P 
content in the pieces, excised from the gel, was 
estimated by liquid scintillation counting. CaZ+ 
uptake activity was measured by incubation of SR 
with 50 PM 45Ca in the presence of 1 mM ATP [3]. 
After the incubation the 45Ca-containing SR vesicles 
were filtered through Millipore filters (0.45 pm). The 
45Ca content of the SR vesicles remaining on the 
filters was estimated by liquid scintillation counting 
[3]. Ca*+ uptake activity in blank reactions, obtained 
by omitting ATP from the reaction mixture, were 
subtracted. 
Protein. The protein content of SR was estimated 
with the method of Lowry et al. [19]. In the needle 
biopsies, protein was estimated by a procedure other 
than in the crude pellet obtained after centrifugation 
of the homogenate acidified with HClO+ After 
dissolution in 0.1 M KOH, protein was estimated 
with the Coomassie Brilliant Blue assay [20] obtained 
from Bio-Rad (Bio-Rad Laboratories, Munich, 
F.R.G.). For both methods bovine serum albumin 
was used as the standard. 
Drugs. Nisoldipine (Bayer A.G., Wuppertal, 
F.R.G.) was dissolved in a mixture of polyethylene 
glycol 400, glycerol and distilled water. The 
nisoldipine solution (0.1 mg/rnL) was diluted with 
0.9% (w/v) NaCl immediately before use. Prep- 
aration of the solution and administration of 
nisoldipine occurred while the drug was protected 
from light. 
Statistical analysis. All data have been presented 
as means ‘- SE. The significance of the changes 
produced by the LADCA flow reduction in the 
animals was evaluated by Duncan’s new multiple 
range test once an analysis of variance had revealed 
that the samples represented different populations. 
The significance of the nisoldipine-induced changes 
was determined by comparing these changes with 
those observed in the solvent-treated animals at 
corresponding times. Statistical significance was 
accepted for P < 0.05. 
RESULTS 
Ventricular arrhythmias 
In both groups seven out of nine animals (78%) 
encountered an episode of ventricular fibrillation 
during the ischaemic period. All animals were 
defibrillated within 25 set and resumed prefibrillation 
values. Ventricular fibrillation was not observed 
during reperfusion in any animal. 
Systemic haemodynamics 
During the first 30 min of LADCA flow reduction 
in the solvent-treated animals mean arterial blood 
pressure, cardiac output, stroke volume and LVdP/ 
d&x had decreased (P < 0.05) by 23, 30, 36 and 
32%) respectively, left ventricular end diastolic 
pressure increased from 8 to 13 mmHg (P < 0.05), 
while heart rate was not affected (Table 1). During 
the 2 hr of reperfusion there was a further decline 
in mean arterial blood pressure (to 59% of baseline), 
LVdP/dt,,, (to 54% of baseline), cardiac output (to 
52% of baseline) and stroke volume (to 56% of 
baseline), while left ventricular end diastolic pressure 
further increased to 14 2 2 mmHg. Vasoconstriction 
(increase in systemic vascular resistance to 35% 
above baseline) prevented a more severe fall in 
mean arterial blood pressure (Table 1). During 
ischaemia there were similar decreases in mean 
arterial blood pressure, cardiac output, stroke 
volume and LVdP/dt,,,,, in the nisoldipine-treated 
animals (Table 1). During reperfusion cardiac output 
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Table 1. Systemic haemodynamicsinsolvent-treatedandnisoldipine-treatedopen-chestanaesthetized 
pigs at baseline (BL), 30 and 60 min of ischaemia (I) and 120 min of reperfusion (R). Nisoldipine 
(0.1 pg/kg/min) was started at 30 min of ischaemia and lasted throughout reperfusion 
BL 
MAP SOL 97 + 5 
NIS 90 2 4 
CO SOL 2.3 2 0.1 
NIS 2.5 + 0.2 
HR SOL 94 2 5 
NIS 95 2 4 
LVdP/dl,,, SOL 2590 ? 130 
NIS 2390 t 160 
30 I 
75 +5* 
66 ” 5* 
1.6 t O.l* 
1.8 * 0.1* 
98 * 4 
100 t 6 
1760 ‘- 120* 
1690 + 90* 
60 I 
72 + 3* 
65 ? 3* 
1.6? O.l* 
1.8 2 O.l* 
95 * 7 
97 r 4 
1850 + 140* 
1550 ” 120* 
120 R 
57 + 4* 
65 ? 6*$9 
1.2 2 0.2* 
1.6 ? 0.2*$ 
88 + 8 
103 + 8 
1390 2 230* 
1900 -c 24o*ts 
LVEDP SOL 821 13 2 1’ 122 1* 14 t 2* 
NIS 10-c 1 15*1* 14 t 1* 13 2 l*B 
SV SOL 25 2 2 17 + 2* 18 _C 2* 14 2 2*- 
NIS 27 + 2 18 -e 2* 19r 1* 16 ? 2* 
SVR SOL 43 2 3 48 ‘- 4 46 2 3 58 ” 10 
NIS 38 ? 2 40 2 3 37 2 2 40 t 4 
MW SOL 225 ” 16 121 + 16 118 2 14* 69 ? 14* 
NIS 222 t 18 130 ? 13 124 2 ll* 111 r 15*$§ 
Data are presented as means 2 SE; N = 9 for both groups; SOL = solvent-treated, NIS = 
nisoldipine-treated; MAP = mean arterial blood pressure (mmHg); CO = cardiac output (L/min); 
HR =heart rate (beats/min); LVdP/dt,,, = maximum rise in left ventricular pressure (mmHg/sec); 
LVEDP = left ventricular end diastolic blood pressure (mmHg); SV = stroke volume (mL); SVR = 
systemic vascular resistance (mmHg/(L/min)); MW = myocardial work (mmHg.L/min). 
* P < 0.05 versus baseline; 
t nisoldipine-induced changes versus baseline are significantly different from changes in the 
solvent-treated animals; 
$ nisoldipine-induced changed versus 30 min of ischaemia re significantly different from changes 
in the solvent-treated animals; 
I nisoldipine-induced changes versus 60 min of ischaemia re significantly different from changes 
in the solvent-treated animals. 
further declined; the decrease versus baseline was, 
however, significantly smaller than in the solvent- 
treated animals (Table 1). Mean arterial blood 
pressure did not further decrease and LVdP/dt,,,,, 
even increased (P < 0.05 versus changes in solvent- 
treated animals). Left ventricular end diastolic 
pressure decreased from 14 2 1 to 13 + 1 mmHg, 
which was significantly different from the increase, 
observed in the solvent-treated animals. Heart rate 
was not affected and stroke volume decreased 
similarly as in the solvent-treated animals. 
Regional myocardial perfusion and myocardial 
oxygen consumption 
The microsphere data revealed that inflation of 
the balloon had caused similar decreases in 
transmural myocardial blood flow in the solvent- 
treated (from 82 t 5 mL/min/lOO g to 19 2 9 mL/ 
min/lOO g) and the nisoldipine-treated animals (from 
87 * 12 to 14 ? 8 mL/min/lOO g, Fig. 1) during the 
first 30min of ischaemia. There were no further 
changes in the solvent-treated animals during the 
following 30min of LADCA stenosis (LADCA 
blood flow was 19 ? 6 mL/min/lOO g at 30 min of 
ischaemia). In the nisoldipine-treated animals 
myocardial blood flow increased from 14 2 8 mL/ 
min/lOO g to 24 ? 6 mL/min/lOO g. After 2 hr of 
reperfusion transmural myocardial blood flow of the 
LADCA-perfused area had increased to 41 2 6 mL/ 
min/lOO g and 76 * 14 mL/min/lOO g in the solvent- 
treated and the nisoldipine-treated animals, respect- 
ively (P C 0.05 versus 60 min of ischaemia; Fig. 1). 
In both the solvent- and the nisoldipine-treated 
animals transmural blood flow to the non-ischaemic 
area decreased slightly during ischaemia, secondary 
to the fall in arterial blood pressure. However, during 
reperfusion, vasodilatation prevented perfusion 
decreasing parallel to the fall in perfusion pressure 
in the nisoldipine-treated but not in the solvent- 
treated pigs. 
Baseline values of myocardial oxygen consumption 
of the LADCA-perfused myocardium were 
2.9 ? 0.3 mL Oz/min/g and 3.5 2 0.5 mL O*/min/g 
in the solvent-treated and the nisoldipine-treated 
animals, respectively. After 2 hr of reperfusion 
these respective values were 0.56 * 0.06 and 
1.18 ‘- 0.30 mL O*/min/g (P > 0.05). 
Regional myocardial wall function 
Reduction of coronary blood flow totally abolished 
systolic wall thickening of the segment perfused by 
the LADCA in both groups (baseline values in the 
nisoldipine-treated and the solvent-treated animals 
were 31 t 4% and 33 ? 4%, respectively), which 
did not change in either group neither during the 
remainder of the ischaemic episode nor during 
the reperfusion period. PSWT of the ischaemic 
myocardium after 30 and 60min of ischaemia was 
11 ? 1% and 8 ? 1% in the solvent-treated, and 
10 2 2% and 10 * 2% in the nisoldipine-treated 
animals, respectively. 
High energy phosphates 
During ischaemia and reperfusion there were no 
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Non- ischaemic Ischoemic 
Fig. 1. Transmurai myocardial blood flow (mL/min/l~ g) of non-ischaemic and ischaemic myocardium 
in solvent-treated (open bars, N = 9) and nisoldipine-treated (hatched bars, N = 9) pigs at baseline 
(BL), after 30 and 60 min of ischaemia (I), and 120 min of reperfusion (R). (*) P < 0.05 versus baseline, 
(+) changes versus baseline in the nisoldipine-treated animals are significantly different from the 
changes versus baseline in the solvent-treated animals; (a) changes versus 60 min of ischaemia in the 
nisoldipine-treated animals are significantly different from the changes versus 60 min of ischaemia in 
the solvent-treated animals. 
Non- whoemic Ischaemic 
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Fig. 2. ATP and CP (pmoI/g protein) and energy charge [(ATP + ~ADP)/(ATP + ADP 4 AMP)] of 
the ischaemic and non-ischaemic myocardium of solvent-treated (open bars, N = 9) and nisoldipine- 
treated pigs (hatched bars, N = 9) at baseline (BL), at 30 min (only for the ischaemic segment) and 
60min of ischaemia (I) and after 120min of reperfusion (R). (*)P < 0.05 versus baseline; (#) 
changes versus 30 min of ischaemia in the nisoldipine-treated animals are significantly different from 
changes versus 30 min of ischaemia in the solvent-treated animals: (0) changes versus 60 min of 
ischaemia in the nisoldipine-treated animals are significantly different from the changes versus 60 min 
of ischaemia in the solvent-treated animals. 
changes in the levels of ATP, adenine nucleotides of CP and total creatine decreased in the nisoldipine- 
and the energy charge in the non-ischaemic treated animals while there was a slight increase in 
myocardium of both the solvent- and the nisoldipine- the solvent-treated animals (P C 0.05; Figs 2 and 3). 
treated animals (Figs 2 and 3). The concentrations After 2 hr of reperfusion the differences between 
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Non -Ischoemlc Ischoemlc 
Fig. 3. Total adcnine nucleotides (ATP + ADP 4 AMP) and total creatine (CP f creatine) of the non- 
ischaemic and ischaemic myocardium in solvent-treated (open bars, N = 9) and nisoldipine-treated 
(hatched bars, N = 9) pigs at baseline (BL), at 30 min (only for the ischaemic segment) and 60 min of 
ischaemia (I) and after 120 min of reperfusion (R). (*) P < 0.05 versus baseline; (0) changes versus 
60 min of ischaemia in the nisoldipine-treated animals are significantly different from the changes versus 
60 min of ischaemia in the solvent-treated animals. 
groups in concentrations of CP and total creatine 
were no longer present. 
In the LADCA-perfused myocardium of the 
solvent- and the nisoldipine-treated animals 30 min 
of flow reduction caused decreases in ATP (by 66 
and 68%, respectively), CP (by 70 and 73%, 
respectively) and total adenine nucleotides (47 and 
48%, respectively), while the energy charge 
decreased from 0.90 rt 0.01 and 0.91 i 0.01 in the 
nisoldipine- and solvent-treated animals, respect- 
ively, to 0.69 i 0.04 in both groups. During the 
following 30 min of ischaemia in the solvent- but not 
in the nisoldipine-treated animals the Ievel of 
ATP and the energy charge further decreased. 
Furthermore, the increase in CP to 92 * 24% of 
baseline observed in the nisoldipine-treated animals 
was absent in the solvent-treated pigs. The total 
creatine pool showed no changes in the solvent- 
treated animals during ischaemia, while a slight but 
significant decrease was observed in the nisoldipine- 
treated animals after 30 min of ischaemia. After 2 hr 
of reperfusion no recovery of the levels of ATP and 
total adenine nucleotides was observed in either 
group, while those of CP were at baseline and the 
energy charge had recovered similarly in both groups 
to 0.83 5 0.03. The level of total creatine remained 
2.5 and 35% below baseline in the nisoldipine- and 
the solvent-treated animals, respectively. 
Ca2+ uptake and phospholamban phosphoryiation 
Ca2+ uptake and in vitro phosphorylation of 
phospholamban could only be determined at the end 
of reperfusion because of the amount of myocardium 
(5 g), needed for the isolation of sufficient amounts 
of SR membrane vesicles. The rate of Ca2’ uptake 
of the non-ischaemic segment of the nisoldipine- 
treated animals was 61% higher (P < 0.0s) than that 
of the solvent-treated animals, and phospholamban 
phosphorylation, on the other hand, was 33% lower 
(PcO.05). (Table 2) The rates of Ca2+ uptake of 
SR vesicles isolated from post-ischaemic segments 
were not different: 531 ? 94 nmol/min/mg and 
727 * 212 nmol/min/mg in the solvent-treated and 
the nisoldipine-treated animals, respectively. The in 
vitro 32P incorporation remained 43% lower in the 
nisoldipine-treated (765 * 96 pmol/mg) compared 
to the solvent-treated animals (1336 + 263 pmol/ 
mg). 
DISCUSSION 
The present study demonstrates that nisoldipine 
increased post-ischaemic myocardial blood flow. 
This could be due to a direct coronary vasodilatory 
action of the drug, since vascular resistance 
of the non-ischaemic myocardium decreased 
(from 0.91 2 0.09 mmHg/(mL/min/lOO g) to 
0.74 2 0.10 mmHg/(mL/min/lOO g) (P < 0.05 ver- 
sus baseline) in the nisoldipine-treated animals, 
whereas there was no change in the solvent-treated 
animals (baseline 1.02 mmHg/(mL/min/lOO g)). 
However, the higher myocardial oxygen demand 
reflected by the higher double-product (heart rate 
times systolic arterial pressure) in the nisoldipine- 
treated animals (94 x lo2 ? 11 x 102 mmHg.beats/ 
min versus 71 x IO2 2 11 x IO2 mmHg.beats/min in 
the solvent-treated pigs) also contributes to the 
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Table 2. Effect of nisoldipine or its solvent on Ca*+ uptake and in vitro 32P incorporation 
into phospholamban of sarcoplasmic reticulum isolated from post-ischaemic myocardium 







SOL 830 ? 117 1605 2 170 
NIS 1335 f 107* 1083 -+ 48* 
SOL 531 + 94 1336 ” 263 
NIS 727 ? 212 765 2 96* 
Data are presented as means + SE; SOL = solvent-treated (N = 7); NIS = nisoldipine- 
treated (N = 9). 
* P < 0.05 versus solvent-treated animals 
vasodilatation of the coronary bed of the non- 
ischaemic myocardium. 
The failure of tissue to reperfuse after a transient 
ischaemic period has been called the no-reflow 
phenomenon. The higher blood flow in the post- 
ischaemic myocardium in the nisoldipine-treated 
animals could also be secondary to attenuation of 
this phenomenon by nisoldipine. The mechanisms 
by which nisoldipine can preserve cardiomyocytes 
and endothelial cells are diverse. Takahashi and 
Kako [21] demonstrated that nisoldipine was capable 
of suppressing the ischaemia-induced increase 
in phospholipid breakdown of canine cardiac 
sarcolemma. It has also been shown that nisoldipine 
decreased transcoronary extravasation [12] and the 
authors postulated that secondary to a reduction 
in Ca*+ uptake during reperfusion, nisoldipine 
prevented endothelial deformation and formation of 
interendothelial gaps. We found that nisoldipine 
caused a significant increase in CP already during 
ischaemia. The further decreases in the level of ATP 
and the energy charge, as observed in the saline- 
treated animals during the last 30 min of ischaemia, 
were prevented in the nisoldipine-treated pigs, 
albeit that these differences were not significant. 
Nevertheless, since the increase in CP must be a 
consequence of a more rapid rephosphorylation of 
ADP, the energy metabolism in the nisoldipine- 
treated animals during ischaemia must have been 
more favourable. This might have led to preservation 
of jeopardized cells contributing to the maintenance 
of the microvascular integrity. 
Recently, Gross et al. [22] investigated the effect 
of the dihydropyridine amlodipine on subendocardial 
segment length shortening, regional blood tlow and 
myocardial high energy phosphate levels in coronary 
ligated (45 min of total occlusion) dogs followed by 
2 hr of reperfusion). LADCA blood flow during 
ischaemia and systemic haemodynamics in that study 
were similar as those in the present study. However, 
at variance with the present study, Gross et al. [22] 
observed a marked and sustained improvement in 
systolic wall function at the end of the reperfusion 
period. The authors postulated that a positive 
inotropic action, as also observed for the Ca2+ 
antagonist felodipine [23], might have reversed 
myocardial stunning, thereby attenuating the 
rebound in CP. 
In the present study the higher post-ischaemic 
blood flow in the nisoldipine-treated animals was 
not accompanied by a return of systolic contractile 
function during early reperfusion. The explanation 
for this can be four-fold. Firstly, a negative inotropic 
action of the drug prevented return of function, This 
is highly unlikely as in pigs this dose of nisoldipine 
does not cause negative inotropy (241. Secondly, the 
myocardial tissue is irreversibly injured. Garcia- 
Dorado et al. [25] have shown (by tetrazolium- 
staining) that in pigs 30-40% of the myocardium at 
risk was still viable after 1 hr of total coronary artery 
occlusion. In the present study we reduced coronary 
blood flow to U-20% of baseline during the 60 min 
of ischaemia and a significant fraction of the affected 
myocardium must therefore ultimately (even after 
days) recover in function. Thirdly, the low energy 
charge of the post-ischaemic myocardium prevented 
contractile function. However, it has repeatedly 
been demonstrated that enhanced recovery of 
function occurs while the ATP-levels are still low 
[26-281. Finally, Krause et al. [29] have suggested 
that the inability of the stunned myocardium to 
function normally is due to a slight reduction of the 
activity of the Ca2+ pump. 
Ca2+-uptake in the non-ischaemic myocardium of 
the nisoldipine-treated pigs was higher than that 
of the solvent-treated animals. Two possible 
mechanisms of action can be forwarded: (i) a direct 
stimulation of the pump by nisoldipine is involved 
since it has been demonstrated that dihydropyridines 
stimulate Ca2+ uptake of canine cardiac sarcoplasmic 
reticulum [7] and interestingly also of porcine cardiac 
sarcolemma [30]. However, this mechanism of action 
may be expected to be masked by the SR isolation 
procedure, during which drugs are removed from 
their target proteins or phospholipids. On the other 
hand, the lipophilic nature of the dihydropyridines 
[31] may have retarded their removal from the 
phospholipid bilayer; (ii) the activation of the Ca2+ 
pump is secondary to a /3-adrenoceptor-mediated 
mechanism. In the nisoldipine-treated animals the 
LVdPjdt,,, was significantly increased and there 
was a tendency for the heart rate to increase, both 
suggesting a higher level of /I-adrenoceptor activity. 
The nisoldipine-induced decrease in in vitro 32P 
incorporation of phospholamban, found in the non- 
ischaemic myocardium, is in agreement with an 
increased Padrenoceptor activity causing an in vivo 
phosphorylation of the protein, although rapid 
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dephosphorylation of sarcolemmal phospholamban 11. Nigdikar SV and Bowditch Dow JW, Calcium 
has been shown to occur during the homogenization antagonists and adenine nucleotide metabolism in rat 
and fractionation of the myocardial tissue needed heart. Cardiovasc Res 20: 604-608, 1986. 
for isolation of the membrane vesicles [18]. 12. McDonagh PF and Roberts DJ, Prevention of 
Therefore, to definitely prove that the increase of ~ranscoronary macromolecular leakage after ischemia- 
Ca2+ uptake rate and decrease of in vitro 32P 
reperfusion by the calcium entry blocker nisoldipine. 
incorporation in myocardium by nisoldipine is due 
Circ Res 58: 127-136, 1986. 
to increased Padrenoceptor activity, the degree of 
13. Daly MJ, Elz JS and Nayler WG, The effect of 
verapamil on ischaemia-induced changes to the 
phosphorylation of phospholamban should be sarcolemma. J Mol Cell Cardiol 17: 667-674, 1985. 
measured in vivo. We have no explanation for the 14. Nayler WG, Ferrari R and Williams A, Protective 
lack of a significant increase of Ca2’ uptake by effect of pretreatment with verapamii, nifedipine and 
nisoldipine in the ischaemic myocardium. propranoiol on mitochondriai function in the ischemic 
A lower in uitro 32P incorporation into phos- and reperfused myocardium. Am J Cardiol44: 242- 
pholamban in ischaemic myocardium has been 
248, 1980. 
associated with a modification of the structure or 
15. Saxena PR, Schamhardt HC, Forsyth RP and Loeve 
membrane component of the protein [3, 18,321. 
J, Computer programs for the radioactive microsphere 
Evidence has been obtained that the reduction in 
technique. Determination of regional blood flows and 
other haemodynamicvariables in different experimentai 
sarcoplasmic reticulum Ca2+ pump is causally related circumstances. Camp F’rogr Biomed 12: 63-84, 1980. 
with the modified properties of phospholamban [3]. 16. Saxena PR and Verdouw PD, Redistribution by 5- 
We found a reduced Ca*+ uptake and in vitro 32P hydroxytryptamine of carotid arterial blood at the 
incorporation into phospholamban of the ischaemic expense of arteriovenous anastomotic blood Bow. J 
segments of both the solvent- and the nisoldipine- Physio1332: 501-520, 1982. 
treated animals. However, the effects of nisoldipine 17. Sellevold OFM, Jynge P and Aarstad K, High 
on Ca2+ uptake and in vitro 32P-incorporation 
into phosp~olamban observed in the ischaemic 
myocardium tend to be similar to those in the non- 
ischaemicmyocardium. Therefore, theinterpretation 18. 
of the nisoldipine-induced effects on SR function 
during ischaemia-reperfusion are complicated by a 
possible direct or @-adrenoceptor-mediated action 
of the drug. 
performance liquid chromatography: a rapid isocratic 
method for determination of creatine compounds and 
adenine nucfeotides in myocardiai tissue. J Mot Cell 
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